These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 16001963)
1. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy. Zaak D; Karl A; Knüchel R; Stepp H; Hartmann A; Reich O; Bachmann A; Siebels M; Popken G; Stief C BJU Int; 2005 Aug; 96(2):217-22. PubMed ID: 16001963 [TBL] [Abstract][Full Text] [Related]
2. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit. Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis. Burger M; Zaak D; Stief CG; Filbeck T; Wieland WF; Roessler W; Denzinger S Eur Urol; 2007 Jul; 52(1):142-7. PubMed ID: 17267099 [TBL] [Abstract][Full Text] [Related]
4. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204 [TBL] [Abstract][Full Text] [Related]
5. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660 [TBL] [Abstract][Full Text] [Related]
6. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer. Witjes JA; Douglass J Nat Clin Pract Urol; 2007 Oct; 4(10):542-9. PubMed ID: 17921969 [TBL] [Abstract][Full Text] [Related]
7. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. Rink M; Babjuk M; Catto JW; Jichlinski P; Shariat SF; Stenzl A; Stepp H; Zaak D; Witjes JA Eur Urol; 2013 Oct; 64(4):624-38. PubMed ID: 23906669 [TBL] [Abstract][Full Text] [Related]
8. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. Daniltchenko DI; Riedl CR; Sachs MD; Koenig F; Daha KL; Pflueger H; Loening SA; Schnorr D J Urol; 2005 Dec; 174(6):2129-33, discussion 2133. PubMed ID: 16280742 [TBL] [Abstract][Full Text] [Related]
9. [Fluorescence cystoscopy at bladder cancer: present trials]. Zaak D; Karl A; Stepp H; Tritschler S; Tilki D; Burger M; Knuechel R; Stief C Urologe A; 2007 Nov; 46(11):1519-27. PubMed ID: 17928985 [TBL] [Abstract][Full Text] [Related]
10. [Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis]. Kausch I; Sommerauer M; Montorsi F; Stenzl A; Jacqmin D; Jichlinski P; Jocham D; Ziegler A; Vonthein R Aktuelle Urol; 2010 May; 41(3):171-7. PubMed ID: 20486035 [TBL] [Abstract][Full Text] [Related]
12. [Value of the photodynamic method in the diagnosis of superficial bladder tumors]. Lipiński MI; Jeromin LM Wiad Lek; 2004; 57 Suppl 1():192-5. PubMed ID: 15884237 [TBL] [Abstract][Full Text] [Related]
13. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology. Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151 [TBL] [Abstract][Full Text] [Related]
14. Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma? Sim HG; Lau WK; Olivo M; Tan PH; Cheng CW BJU Int; 2005 Jun; 95(9):1215-8. PubMed ID: 15892804 [TBL] [Abstract][Full Text] [Related]
15. [The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer]. Daniltchenko D; Riedl C; Koenig F; Daha LK; Sachs M; Schnorr D Aktuelle Urol; 2004 Nov; 35(6):497-501. PubMed ID: 15526230 [TBL] [Abstract][Full Text] [Related]
16. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Denzinger S; Burger M; Walter B; Knuechel R; Roessler W; Wieland WF; Filbeck T Urology; 2007 Apr; 69(4):675-9. PubMed ID: 17445650 [TBL] [Abstract][Full Text] [Related]
17. Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trial. Stenzl A; Penkoff H; Dajc-Sommerer E; Zumbraegel A; Hoeltl L; Scholz M; Riedl C; Bugelnig J; Hobisch A; Burger M; Mikuz G; Pichlmeier U Cancer; 2011 Mar; 117(5):938-47. PubMed ID: 21351082 [TBL] [Abstract][Full Text] [Related]
18. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer. Inoue K; Fukuhara H; Shimamoto T; Kamada M; Iiyama T; Miyamura M; Kurabayashi A; Furihata M; Tanimura M; Watanabe H; Shuin T Cancer; 2012 Feb; 118(4):1062-74. PubMed ID: 21773973 [TBL] [Abstract][Full Text] [Related]
19. Improved detection and reduced early recurrence of non-muscle-invasive bladder cancer using hexaminolaevulinate fluorescence cystoscopy: results of a multicentre prospective randomized study (PC B305). Mostafid H; Bunce C; BJU Int; 2009 Oct; 104(7):889-90. PubMed ID: 19549121 [No Abstract] [Full Text] [Related]
20. [Fluorescence diagnosis and photodynamic therapy in urology]. Stepp H; Waidelich R Aktuelle Urol; 2007 Nov; 38(6):455-64. PubMed ID: 17987533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]